Gregório Cavalcante, MSc
Visiting Scientist
Lab member: Rutgers (2021-2022)
Project: Cloning and Expression of SPT of Bacteroides/S24-7 from fecal microbiota. The role of Amuc_1100 from Akkermansia muciniphila on inflammation markers.
Last known affiliation: Clinical Pharmacist - Hospital Estadual Central, Brazil (2025)
PhD
Education
B.S. Pharmacy, Universidade Federal do Espírito Santo, 2014
MSc. Biochemistry and Immunology, Universidade Federal de Minas Gerais, 2018
Bio
Gregório Cavalcante's research focuses on the role of antibiotics in early life and their impacts of allergic asthma. Gregório also studies probiotics as novel therapies for allergic asthma.
Research Focus
Microbiome, Immunology, Antibiotics, Probiotics, Allergic asthma
SBI Travel Awards, Brazilian Society of Immunology, 2017.
Work recognized with Academic Relevance by the III Symposium of Microbiology of Universidade Federal de Minas Gerais, 2016.
1.
Trindade L, Torres L, Matos I, et al. Paraprobiotic Lacticaseibacillus rhamnosus Protects Intestinal Damage in an Experimental Murine Model of Mucositis. Probiotics and antimicrobial proteins. 2021. doi:10.1007/s12602-021-09842-z.